- Home
- CAAS vs ZNTL Comparison
CAAS vs ZNTL Comparison
Compare CAAS & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAS
- ZNTL
- Stock Information
- Founded
- CAAS N/A
- ZNTL 2014
- Country
- CAAS China
- ZNTL United States
- Employees
- CAAS N/A
- ZNTL N/A
- Industry
- CAAS Auto Parts:O.E.M.
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- CAAS Consumer Discretionary
- ZNTL Health Care
- Exchange
- CAAS Nasdaq
- ZNTL Nasdaq
- Market Cap
- CAAS 130.9M
- ZNTL 105.8M
- IPO Year
- CAAS N/A
- ZNTL 2020
- Fundamental
- Price
- CAAS $4.18
- ZNTL $1.26
- Analyst Decision
- CAAS
- ZNTL Buy
- Analyst Count
- CAAS 0
- ZNTL 7
- Target Price
- CAAS N/A
- ZNTL $8.60
- AVG Volume (30 Days)
- CAAS 21.0K
- ZNTL 1.3M
- Earning Date
- CAAS 08-12-2025
- ZNTL 08-08-2025
- Dividend Yield
- CAAS 19.14%
- ZNTL N/A
- EPS Growth
- CAAS N/A
- ZNTL N/A
- EPS
- CAAS 0.96
- ZNTL N/A
- Revenue
- CAAS $678,635,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- CAAS N/A
- ZNTL N/A
- Revenue Next Year
- CAAS N/A
- ZNTL N/A
- P/E Ratio
- CAAS $4.38
- ZNTL N/A
- Revenue Growth
- CAAS 18.33
- ZNTL N/A
- 52 Week Low
- CAAS $3.34
- ZNTL $1.01
- 52 Week High
- CAAS $5.37
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- CAAS 50.38
- ZNTL 45.95
- Support Level
- CAAS $4.06
- ZNTL $1.13
- Resistance Level
- CAAS $4.24
- ZNTL $1.39
- Average True Range (ATR)
- CAAS 0.13
- ZNTL 0.11
- MACD
- CAAS -0.02
- ZNTL -0.02
- Stochastic Oscillator
- CAAS 35.29
- ZNTL 31.71
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.